Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03847597
Other study ID # 7168
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2019
Est. completion date February 2022

Study information

Verified date December 2018
Source University Hospital, Strasbourg, France
Contact Nabil CHAKFE
Phone +33 3 69 55 08 88
Email nabil.chakfe@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The femoro-popliteal arterial segment is one of the most frequent locations for atherosclerosis. Its management is mainly endovascular (standard and coated-balloon angioplasty, stenting).

However, the structural features of the atherosclerotic disease in regards to patient's risk factors and past medical and surgical histories are not well studied. Furthermore, the histological analysis of the femoro-popliteal arterial segment is rare in the literature, and made difficult mostly because of the length of this segment.

There is a clinical need for better understanding of atherosclerotic lesions in this location, with as further goal, a better management of this disease.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date February 2022
Est. primary completion date April 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- Age > 18 years old

- Men and women

- Patient with chronic limb ischemia that is scheduled for transfemoral amputation in the University Hospital of Strasbourg

- Patient giving his -non-opposition to the explantation and use of the femoro-popliteal arterial segment

Exclusion criteria:

- Refusal to give his consent

- Impossibility to give clear information to the patient

- Pregnant and breastfeeding women

- Patient under administrative protection

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Explantation of the femoro-popliteal arterial segment from the amputed limb
Explantation of the femoro-popliteal arterial segment from the amputed limb

Locations

Country Name City State
France Les Hôpitaux Universitaires de Strasbourg Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Descriptive analysis of the arterial structure in micro-CT. study precisely the pathological structure of the femoro-popliteal arterial segment in AOMI, both in imaging and histologically. 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT00768495 - Hyperspectral Imaging Pre and Post Endovascular Intervention N/A
Completed NCT03294902 - Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System
Active, not recruiting NCT02908035 - Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO) Phase 2
Active, not recruiting NCT02479620 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization Phase 2
Recruiting NCT02479555 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization Phase 2
Recruiting NCT06416644 - The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) N/A